Company offers 1.8 million of its common shares through offering
By Devika Patel
Knoxville, Tenn., June 8 – Miramar Labs, Inc. said it raised about $9 million in a private placement of stock.
The company sold 1.8 million common shares.
Investors included Domain Associates, Morgenthaler Partners, Aisling Capital, RusnanoMedInvest (RMI), Cross Creek Advisors, and Montrose Capital Partners.
Proceeds will be used for commercialization of the miraDry system, development and clinical studies and general corporate purposes, including working capital.
Miramar also announced that it has completed a reverse merger with Miramar Technologies, Inc.
The global medical device company is based in Santa Clara, Calif.
| Issuer: | Miramar Labs, Inc.
|
| Issue: | Common stock
|
| Amount: | $9 million (approximate)
|
| Shares: | 1.8 million
|
| Warrants: | No
|
| Investors: | Domain Associates, Morgenthaler Partners, Aisling Capital, RusnanoMedInvest (RMI), Cross Creek Advisors, and Montrose Capital Partners
|
| Settlement date: | June 8
|
| Stock symbol: | OTCBB: MIRA
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
